节点文献

DICE作为二线方案治疗难治或复发性非霍奇金淋巴瘤

DICE Regime as the Second for Refractory or Relapsed Non-Hodgkin’s Lymphoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 路平冷传春梅家转

【Author】 LuPingLengChuanchunMeiJiazhuanDepartmentofOncology,theFirstHospitalofXinxiangMedicalUniversity,Xinxiang

【机构】 河南新乡医学院第一附属医院肿瘤科辽宁省鞍山市中心医院肿瘤科河南新乡医学院第一附属医院肿瘤科 河南省新乡市453100河南省新乡市453100

【摘要】 目的:观察DICE作为二线方案治疗难治或复发性非霍奇金淋巴瘤(NHL)有效性及不良反应耐受性。方法:采用DICE方案治疗28例复发或难治性非霍奇金淋巴瘤。其中,复发组16例,难治组12例并探讨足三里穴位封闭或粒细胞集落刺激因子(G-CSF)预防化疗对造血系统的抑制作用。结果:28例中,完全缓解CR7例(25.0%),部分缓解PR8例(28.6%),有效率53.6%。复发组的有效率明显高于难治组(10/16比4/12;P<0.01)。乳酸脱氢酶(LDH)升高12例中CR2例,LDH正常组16例CR5例,有显著性差异(P<0.01)。DICE方案的不良反应主要表现为恶心呕吐、脱发和可逆性骨髓抑制,患者均能耐受,无1例出现治疗相关性死亡。结论:DICE方案对复发性NHL有效,但对难治性NHL相对无效,提示复发性和难治性NHL可能有不同的生物学行为,对两者应该选择不同的治疗措施,LDH可以作为NHL化疗是否敏感的指标之一。

【Abstract】 Objective:To explore ef fi ciency and toxicity of DICE regimen as second-line chemotherapy in refractory o r relapsed non-Hodgkin’s lymphoma.Methods:28patients for refrac-tory or re lapsed non-Hodgkin’s lymphoma were treated by DICE regimen.Blocking acupunctu re points of Zusanli with dexamethasone or granulocyte colony-stimulating facto r (G-CSF)against myelosupression induced by chemotherapy.Results:A complete response was seen in7patients(25.0%),and a partial response was noted in8patients(28.6%).A significantly higher response rate was seen in pat ients with relapsing non-Hodgkin lymphoma compared with those who failed to ac hieve a complete response with the last chemotherapy(13/16vs.2/12;P <0.01).Low response rate for high LDH group compared to that in normal gr oup.Toxicity was nausea/vomiting,alope-cia and reversible myelosuppression .All the patients can tolerance the side effects and there was one drug-relate d death associated with myelotoxicity.Conclusion:DICE regime was a relatively safe and highly efficient salvage for relapsed but not refractory NHL,this s uggested the there may be different biology character between both them and dif ferent strategies should be provided for them.LDH may be marker for sensitive chemotherapy.

  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2003年05期
  • 【分类号】R733.1
  • 【被引频次】23
  • 【下载频次】84
节点文献中: 

本文链接的文献网络图示:

本文的引文网络